Filing step-change
JOHNPHARMA · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
JOHN PHARMA SEES SIGNIFICANT IMPROVEMENT IN GROSS MARGIN AND CLOSE PRICE ACROSS Q3 2026, DESPITE A DECLINE IN DAILY VOLUME.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | -2,605.31 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -2,605.31 % | 0 | ▼ |
Cite this
Source: Samhati filing step-change for JOHNPHARMA (2026-10). Observation: JOHN PHARMA SEES SIGNIFICANT IMPROVEMENT IN GROSS MARGIN AND CLOSE PRICE ACROSS Q3 2026, DESPITE A DECLINE IN DAILY VOLUME. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/johnpharma/q/2026-10
Other periods